抗体

IV型胶原甲4(COL4a4)多克隆抗体

MBS2032561

0.01毫克

110美元

多克隆

兔

未共轭

免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀

抗体

IV型胶原甲4(COL4a4)多克隆抗体

[IV型胶原甲4]

[COL4-A4; CA44; Collagen Alpha-4(IV)chain; Collagen Of Basement Membrane, Alpha-4 Chain]

[胶原甲4(IV)链;胶原甲4(IV)链;胶原甲4(IV)链;IV型胶原甲4链]

[COL4a4]

[COL4A4;COL4A4;CA44]

多克隆

兔

Antigen,specific affinity chromatography followed by Protein A affinity chromatography

Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

0.45毫克/毫升

Storage: Avoid repeated freeze/thaw cycles. Store at 4ºC for frequent use. Aliquot and store at -20ºC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

免疫印迹(免疫印迹), 免疫组化(免疫组化), 免疫细胞化学(免疫细胞化学), 免疫沉淀(免疫沉淀)

Western blotting: 0.5-2 ug/mL;1:220-90. Immunohistochemistry: 5-20 ug/mL;1:22-90. Immunocytochemistry: 5-20 ug/mL;1:22-90. Optimal working dilutions must be determined by end user.

免疫印迹(免疫印迹)

免疫组化(免疫组化)

Organism Species: Homo sapiens (Human). Source: Polyclonal antibody preparation. Traits: Liquid. Immunogen: Recombinant COL4a4 (Val1469~Ser1690) expressed in E.coli.

116256356

NP_000083.3

NM_000092.4

P53420

Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway (730306); Axon Guidance Pathway (105688); Collagen Biosynthesis And Modifying Enzymes Pathway (645289); Collagen Formation Pathway (645288); Developmental Biology Pathway (477129); ECM-receptor Interaction Pathway (83068); ECM-receptor Interaction Pathway (479); Extracellular Matrix Organization Pathway (576262)

This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]

COL4A4: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Defects in COL4A4 are a cause of Alport syndrome autosomal recessive (APSAR). APSAR is characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. Defects in COL4A4 are a cause of benign familial hematuria (BFH); also known as thin basement membrane nephropathy. BFH is characterized by persistent hematuria, an electron microscopically detectable thin glomerular basement membrane (GBM) and an autosomal dominant mode of inheritance. Renal function remains normal. In children, differentiation between BFH and AS can be difficult, because both disorders are manifested by persistent hematuria and thin GBM at that age. Belongs to the type IV collagen family. Protein type: Secreted; Secreted, signal peptide. Chromosomal Location of Human Ortholog: 2q36.3. Cellular Component: basal lamina; collagen type IV; endoplasmic reticulum lumen; extracellular region. Molecular Function: extracellular matrix structural constituent. Biological Process: collagen catabolic process; extracellular matrix organization; glomerular basement membrane development. Disease: Alport Syndrome, Autosomal Recessive

0.01毫克

110美元

0.02毫克

130

0.05毫克

175

0.1毫克

225

0.2毫克

340

1毫克

800